TEG has been used together with platelet mapping as a preand post-operative assessment tool in patients scheduled for surgery or invasive cardiovascular procedures and who have been treated previously with anti-platelet aggregation therapy; although the papers reviewed show good results in terms of guidance for transfusion therapy and for predicting complications, these techniques still have some limitations such as their correlation with the pharmacokinetic and pharmacodynamic properties of the drugs.
La TEG se ha usado en conjunto con la monitorización de la función plaquetaria platelet mapping como una herramienta de valoración prequirúrgica y posquirúrgica para pacientes que van a ser sometidos a cirugía o procedimientos invasivos cardiovasculares y han sido tratados previamente con terapia de anti-agregación plaquetaria.